GSK "OPERNYY", Novosibirsk Oblast

Economic indicators

Net profit (RAS) of GSK OPERNYY grew over 2023 by 28.83% to 362.00 thousand RUB from 281.00 thousand RUB over 2022, the company informed.

Revenue increased in the accounting period by 8.49% to 1.14 million RUB from 1.05 million RUB over 2022; cost of goods sold grew by 0.55% to 730.00 thousand RUB from 726.00 thousand RUB; sales profit went up by 26.40% to 407.00 thousand RUB from 322.00 thousand RUB.

Net profit (RAS) of GSK OPERNYY grew over 2021 by 42.17% to 118.00 thousand RUB from 83.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period by 4.76% to 947.00 thousand RUB from 904.00 thousand RUB over 2020; cost of goods sold grew by 0.89% to 791.00 thousand RUB from 784.00 thousand RUB; sales profit went up by 30.00% to 156.00 thousand RUB from 120.00 thousand RUB.

Revenue increased in the accounting period by 16.34% to 904.00 thousand RUB from 777.00 thousand RUB over 2019.

Net profit (RAS) of GSK OPERNYY made up 0 RUB over 2019 compared to 200.00 thousand RUB over 2018, the company informed.

Revenue decreased in the accounting period by 22.53% to 777.00 thousand RUB from 1.00 million RUB in 2018.

Net profit (RAS) of GSK OPERNYY grew over 2018 by 27.39% to 200.00 thousand RUB from 157.00 thousand RUB over 2017, the company informed.

Revenue increased in the accounting period by 28.43% to 1.00 million RUB from 781.00 thousand RUB over 2017; cost of goods sold grew by 30.03% to 762.00 thousand RUB from 586.00 thousand RUB; sales profit went up by 23.59% to 241.00 thousand RUB from 195.00 thousand RUB.

Net profit (RAS) of GSK OPERNYY grew over 2017 1.52 times to 157.00 thousand RUB from 103.00 thousand RUB over 2016, the company informed.

Revenue increased in the accounting period by 6.69% to 781.00 thousand RUB from 732.00 thousand RUB over 2016; cost of goods sold decreased by 1.01% to 586.00 thousand RUB from 592.00 thousand RUB; sales profit went up by 39.29% to 195.00 thousand RUB from 140.00 thousand RUB.

Net profit (RAS) of GSK OPERNYY dropped in 2016 by 21.37% to 103.00 thousand RUB from 131.00 thousand RUB over the same period in 2015, the company informed.

Revenue increased in the accounting period by 1.95% to 732.00 thousand RUB from 718.00 thousand RUB over 2015; cost of goods sold grew by 7.83% to 592.00 thousand RUB from 549.00 thousand RUB; sales profit fell by 17.16% to 140.00 thousand RUB from 169.00 thousand RUB.

Companies in the region

• ZIMUSHKA
• FIRMA TREYD-SMENA
• URALSERVIS
• NIVA-KHLEB
• "SISTEMA"